Efficacy of 0.5% 5-Fluorouracil Cream and Absence of Undesirable Secondary Effects in the Treatment of Grade III Actinic Keratoses in the Presence of 5% Dobesilate
Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2015, Vol 0, Issue 3
Abstract
Background: 5-Fluorouracil (5-FU) has been a standardized topical treatment for actinic keratosis (AK) lesions, however to treat deep and hyperkeratotic AK a long treatment time is often required. Furthermore, in grade III variant AK, 5-FU normally shows a clear inefficacy. In addition, the drug can cause important inflammatory reactions and scarring. Previous studies performed at our institution reveal that topical potassium dobesilate cream counteracts efficiently skin inflammation. Objective: We propose a combinatorial application of fluorouracil and potassium dobesilate to increase the short-term clearance of grade III AK lesions without cutaneous secondary reactions. Methods: A cream containing 5-FU 0.5% and potassium dobesilate 5% was applied twice daily for 4 to 8 weeks to grade III variant of AK lesions located in the scalp and in the face. The cream was prepared at the Pharmacy Service of the Hospital Universitario Ramón y Cajal in Madrid, Spain. Formulation didn’t contain any keratolytic agent. The lesions were evaluated at an initial baseline visit and every week during 8 weeks. For follow-up observation, patients were also clinically evaluated six months after treatment. Results: There was a 100% clearance rate (12/12) of AK lesions treated with 0.5% fluorouracil and 5% potassium dobesilate cream. Moreover, the cosmetic outcome was excellent. Keywords: Actinic Keratosis; Dobesilate; Flurouracil; Combinatorial Application; Fibroblast Growth Factor. Abbreviations: FGF: Fibroblast Growth Factor; AK: Actinic Keratosis; FU: Fluorouracil.
Authors and Affiliations
Cuevas P
Keywords
Related Articles
- EP ID EP202067
- DOI 10.19070/2167-9118- SI03001 Copyright: Cuevas
- Views 79
- Downloads 0
Frequency and Determining Factors of Empiric Chemotherapy Dose Reduction in Patients with Non-Small Cell Lung Cancer
Objectives: To determine the frequency and key factors regarding empiric chemotherapy dose reductions (ECDR) in nonsmall cell lung cancer (NSCLC) patients. Methods: This retrospective study involved the chart review of...
Therapeutic Potential of Tumor Suppressors in Treating Breast Cancer
Purpose: Tumor suppressor genes participate in a variety of critical and highly conserved cell functions, including regulation of the cell cycle and apoptosis, differentiation, surveillance of genomic integrity and repai...
Efficacy of 0.5% 5-Fluorouracil Cream and Absence of Undesirable Secondary Effects in the Treatment of Grade III Actinic Keratoses in the Presence of 5% Dobesilate
Background: 5-Fluorouracil (5-FU) has been a standardized topical treatment for actinic keratosis (AK) lesions, however to treat deep and hyperkeratotic AK a long treatment time is often required. Furthermore, in grade I...
Work with Cancer in Japan
Work with Cancer in Japan
Intracystic Papillary Carcinoma of The Breast a Rare Tumor in Male
Intracystic papillary carcinoma of the breast in men is an extremely rare disease with an excellent prognosis. Here, we report a new case of intracystic papillary carcinoma of the breast in a 79- year-old man. He was adm...